146 related articles for article (PubMed ID: 3004782)
1. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
Werns SW; Shea MJ; Mitsos SE; Dysko RC; Fantone JC; Schork MA; Abrams GD; Pitt B; Lucchesi BR
Circulation; 1986 Mar; 73(3):518-24. PubMed ID: 3004782
[TBL] [Abstract][Full Text] [Related]
2. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.
Reimer KA; Jennings RB
Circulation; 1985 May; 71(5):1069-75. PubMed ID: 3838707
[TBL] [Abstract][Full Text] [Related]
3. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
Uraizee A; Reimer KA; Murry CE; Jennings RB
Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
[TBL] [Abstract][Full Text] [Related]
4. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
Motoe M; Yoshida S
Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
[TBL] [Abstract][Full Text] [Related]
5. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
[TBL] [Abstract][Full Text] [Related]
6. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
[TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidase inhibition does not limit canine infarct size.
Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
9. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
[TBL] [Abstract][Full Text] [Related]
10. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion.
Werns SW; Simpson PJ; Mickelson JK; Shea MJ; Pitt B; Lucchesi BR
J Cardiovasc Pharmacol; 1988 Jan; 11(1):36-44. PubMed ID: 2450254
[TBL] [Abstract][Full Text] [Related]
11. The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase.
Werns SW; Shea MJ; Driscoll EM; Cohen C; Abrams GD; Pitt B; Lucchesi BR
Circ Res; 1985 Jun; 56(6):895-8. PubMed ID: 2988815
[TBL] [Abstract][Full Text] [Related]
12. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
Puett DW; Forman MB; Cates CU; Wilson BH; Hande KR; Friesinger GC; Virmani R
Circulation; 1987 Sep; 76(3):678-86. PubMed ID: 3621527
[TBL] [Abstract][Full Text] [Related]
13. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts.
Akizuki S; Yoshida S; Chambers DE; Eddy LJ; Parmley LF; Yellon DM; Downey JM
Cardiovasc Res; 1985 Nov; 19(11):686-92. PubMed ID: 3841027
[TBL] [Abstract][Full Text] [Related]
14. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals.
Mitsos SE; Askew TE; Fantone JC; Kunkel SL; Abrams GD; Schork A; Lucchesi BR
Circulation; 1986 May; 73(5):1077-86. PubMed ID: 3698230
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.
Black SC; Schasteen CS; Weiss RH; Riley DP; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1208-15. PubMed ID: 7932173
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol therapy of ischemic heart disease with infarct extension.
Parmley LF; Mufti AG; Downey JM
Can J Cardiol; 1992 Apr; 8(3):280-6. PubMed ID: 1576562
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase as a source of free radical damage in myocardial ischemia.
Chambers DE; Parks DA; Patterson G; Roy R; McCord JM; Yoshida S; Parmley LF; Downey JM
J Mol Cell Cardiol; 1985 Feb; 17(2):145-52. PubMed ID: 3839024
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
Hopson SB; Lust RM; Sun YS; Zeri RS; Morrison RF; Otaki M; Chitwood WR
J Natl Med Assoc; 1995 Jul; 87(7):480-4. PubMed ID: 7636893
[TBL] [Abstract][Full Text] [Related]
20. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit.
Iwamoto T; Miura T; Adachi T; Noto T; Ogawa T; Tsuchida A; Iimura O
Circulation; 1991 Mar; 83(3):1015-22. PubMed ID: 1999006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
